← Every company
Axsome Therapeutics Inc SEC Filings
What Axsome Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AXSM overview →Filings on file
124
since Nov 10, 2016
Warning signs
1
latest Jun 26, 2023
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 9, 2026 | Executive or director change 8-K | Read ↗ |
| Oct 11, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Sep 8, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 21, 2020 | Executive or director change 8-K | Read ↗ |
| Mar 5, 2020 | Executive or director change 8-K | Read ↗ |
| Apr 19, 2018 | Executive or director change 8-K | Read ↗ |
| Jul 7, 2017 | Executive or director change 8-K | Read ↗ |
| Jun 19, 2017 | Executive or director change 8-K | Read ↗ |
Source: Axsome Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AXSM
Company overviewEverything on AXSM in one place, with the price.Insider tradingWhat AXSM's own officers and directors buy and sell.Executive payWhat AXSM awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in AXSM.Funds holding itWhich funds and ETFs hold AXSM, and how big a bet.PatentsWhat AXSM is filing at the patent office.